Frontiers in Oncology

Potentials and Pitfalls for Use of Real-World Data to Inform Clinical Practice 

March 15, 2022 

Tarec Christoffer El-Galaly is a professor of hematology at Aalborg University Hospital, Denmark. His main clinical interest is in the treatment of lymphomas, in particular Hodgkin and aggressive non-Hodgkin lymphomas. His academic interest is in clinical epidemiology and real-world data analytics. Professor El-Galaly has led several national and international studies where real-world data has been utilized to inform clinical practice.

His research has been focused on using real-world data to improve clinical practice for staging, treatment, and post-treatment follow-up of lymphomas. A particular focus has been post-treatment surveillance and late toxicities as well as improving prognostic models for lymphoma by using real-world data and machine learning. The latter includes development of dynamic prognostic models. 

Frontiers in Oncology

Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science.  The dynamic speakers represent a broad range of disciplines and expertise from both Stanford faculty and national thought leaders.  The audience for this seminar series includes Stanford faculty, trainees and staff as well as anyone in the broader community with an interest in cancer research.  Each recorded seminar is approximately 1 hour in length.   


Past Seminars

Upcoming Seminars


Join us on Zoom: http://bit.ly/FIO-Live
Zoom Meeting ID: 918 9681 9052
Passcode: 159826
8:00 am – 9:00 am


  • Amelie Ramirez, DrPH, MPH; UT Health San Antonio - April 5, 2022
  • Electra Paskett, PhD; Ohio State Univ - April 19, 2022
  • Lisa Newman, MD, MPH; Weill Cornell Medical Center - May 17, 2022
  • Robert Winn, MD - August 16, 2022

You may also be interested in the Frontiers in Cancer Clinical Translation Seminar Series sponsored by the Division of Oncology.